Microglia activation in periplaque white matter in multiple sclerosis depends on age and lesion type, but does not

Wiebke Kessler1, Christian Thomas1, Tanja Kuhlmann2

  • 1Institute of Neuropathology, University Hospital Münster, Pottkamp 2, 48149, Münster, Germany.

Acta Neuropathologica
|October 28, 2023
PubMed

Insights

Diffuse microglia activation in multiple sclerosis (MS) brain tissue is influenced by patient age and lesion characteristics. Increased microglia did not correlate with oligodendrocyte loss in periplaque white matter.

Area of Science:

  • Neuroimmunology
  • Central Nervous System (CNS) Pathology

Background:

  • Multiple sclerosis (MS) is a leading cause of inflammatory and demyelinating disease in the CNS.
  • MS progression involves both relapse-driven activity and relapse-independent progression, with mechanisms driving progression less understood.
  • Ongoing inflammation and age-related repair failures are implicated in MS progression.

Purpose of the Study:

  • To investigate diffuse microglia activation in the periplaque white matter (PPWM) of MS patients.
  • To identify factors influencing microglia activation extent in PPWM.
  • To determine the correlation between microglia activation and oligodendrocyte preservation in PPWM.

Main Methods:

  • Analysis of microglial and oligodendroglial cell numbers in PPWM from 32 MS patients and 37 controls.
  • Examination of 96 tissue blocks containing 100 lesions from MS patients.
  • Assessment of factors including patient age, lesion proximity, lesion type, and sex.

Main Results:

  • Microglia activation in PPWM was associated with patient age, proximity to lesions, lesion type, and sex.
  • Oligodendrocyte numbers were reduced in PPWM.
  • Higher microglia densities did not correlate with decreased oligodendrocyte counts in PPWM.

Conclusions:

  • Diffuse microglia activation in PPWM is modulated by patient age and lesion characteristics.
  • Diffuse microglia activation alone is insufficient to cause oligodendrocyte loss in PPWM.
  • Findings support a link between focal and diffuse inflammation in MS, with age as a key modulator.